Table 1

CSF hypocretin-1 in narcoleptic patients with cataplexy

SubjectsCentreAgeSexBMIAge at onset of EDSAge at onset of cataplexyFamily historyECHHSPMSLTSOREMPREM latencyHLA DQB1*0602THypo-1
Centre 1: Montpellier, France; Centre 2: Zurich, Switzerland
F, female; M, male; BMI, body mass index; EDS, excessive daytime sleepiness; E, Epworth sleepiness scale; C, cataplexy severity scale; HH, hypnagogic hallucination; SP, sleep paralysis; Hypo-1, level of hypocretin-1 in the CSF (pg/ml); na, not available (adoptive child)
Family history: 0, none; N, family history of narcolepsy; H, family history of hypersomnia
T, treatment: Psychostimulant or anticataplectic treatment at time of CSF lumbar puncture
*Status cataplecticus for several days when lumbar puncture was made
†HLA DRB1*04/11 -DQB1*03
1136F23.828280183++4361.5+85
2*155F31.646460245+-3.6217++<10
3157M21.5515302330+4.6563+46
4152M25.91515N215++45129++<10
5133M26.8162002340+246++79
6139M27.518270145++442+<10
7119F27.74170123+1.743.5+51
8120F26.41013024102.25368+38
9122M22.61220H174++6.4395.5+126
10117M17.2790185+0.850++<10
11155M26.140500244+6.143.5++<10
12135M29.820190185++1.547++<10
13155M26.82024H1830-6.540.5+25
14113F13.7440185+2.6440+14
15129M24.829290235++350++<10
16123F23.42020H245++1.250++<10
17126F32.6112N245++1.6569.5++<10
18†151F21.825470145++14.6222+271
19126F21.411110195+2.63na++<10
20264M26.34344na1954.545++<10
21234M25.825230183++4.946++<10
22221M20.212140164+5.3515+<10
23252M28.1242402044328++<10
24229M27.517180164+647+<10
25218F18.014120174+2.548+14
26237F22.82020N173++4310+145
Mean (SD)35.3 (15.1)24.6 (4.4)20.5 (13)23.8 (13.5)19.2 (3.5)4.1 (1.03)4.0 (2.7)3.9 (0.9)26.7 (34.7)40.2 (60.2)